Ihre
gewählte
Nachricht : |
|
| Datum : | 02.05.2014 |
Titel : |
DGAP-News: Announcement: 4SC to host conference call on 8 May 2014 to present first quarter results of 2014 |
| Meldung : | DGAP-News: 4SC AG / Key word(s): Miscellaneous Announcement: 4SC to host conference call on 8 May 2014 to present first quarter results of 2014 02.05.2014 / 13:00 --------------------------------------------------------------------- Announcement 4SC to host conference call on 8 May 2014 to present first quarter results of 2014 Planegg-Martinsried, Germany, 2 May 2014 - 4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for cancer and autoimmune diseases, will announce first quarter results 2014 of the 4SC Group and publish the company's report on the first three months of 2014 on 8 May 2014. On this day the Management Board of 4SC AG will host a conference call at 3pm CEST (9am EDT) to inform about the consolidated financial statements and important developments in the reporting period and beyond. Investors, financial analysts, and journalists participating in the conference call can access via the following telephone numbers: Date: 8 May 2014 Time: 3pm CEST (9am EDT) Dial-in numbers: +49-6103-485-3000 (Germany) +44-207-153-2027 (UK) +1-480-629-9726 (USA) +49-6103-485-3000 (other countries) Conference-ID: 4681817 After the conference call a replay will be available in the section "Investors" / "Events & Presentations" / "Conference Calls & Webcasts" of the website www.4sc.com. Ends About 4SC The Group managed by 4SC AG (ISIN DE0005753818) discovers and develops targeted, small-molecule drugs for treating diseases with high unmet medical needs in various cancer and autoimmune indications. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious than existing therapies, and provide a better quality of life. The Company's pipeline comprises promising products that are in various stages of clinical development. 4SC's aim is to generate future growth and enhance its enterprise value by entering into partnerships with leading pharmaceutical and biotech companies. Founded in 1997, 4SC had a headcount of 64 employees (55 FTEs) at 31 March 2014. 4SC AG has been listed on the Prime Standard of the Frankfurt Stock Exchange since December 2005. Cautionary statement regarding forward-looking statements This press release contains certain forward-looking statements. Any forward-looking statement applies only on the date of this press release. By their nature, forward-looking statements are subject to a number of known and unknown risks and uncertainties that may or may not occur in the future and as a result of which the actual results and performance may differ substantially from the expected future results or performance expressed or implied in the forward looking statements. No warranties or representations are made as to the accuracy, achievement or reasonableness of such statements, estimates or projections, and 4SC AG has no obligation to update any such information or to correct any inaccuracies herein or omission herefrom which may become apparent. For more information please visit www.4sc.com or contact: 4SC AG Jochen Orlowski, Corporate Communications & Investor Relations jochen.orlowski(at)4sc.com, Tel.: +49-89-7007-6366 MC Services Katja Arnold, Michelle Kremer katja.arnold(at)mc-services.eu, Tel.: +49-89-2102-2840 The Trout Group Chad Rubin crubin(at)troutgroup.com, Tel.: +1-646-378-2947 End of Corporate News --------------------------------------------------------------------- 02.05.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------- Language: English Company: 4SC AG Am Klopferspitz 19a 82152 Martinsried Germany Phone: +49 (0)89 7007 63-0 Fax: +49 (0)89 7007 63-29 E-mail: public@4sc.com Internet: www.4sc.de ISIN: DE0005753818 WKN: 575381 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 266077 02.05.2014 |
| Sender : | Homepage |